EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma

Yannick Foerster iD, Kristine Mayer, Sophia Wasserer, Marta Dechant, Vitalina Verkhoturova, Sarah Heyer, Tilo Biedermann, Oana-Diana Persa

Cancer Medicine · 2025

DOI: 10.1002/cam4.70631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yannick Foerster und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, TUM School of Medicine and Health, München, Germany. Hauptthemen laut MEDLINE: Melanoma, Neutrophils, Liver Neoplasms, Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Immune checkpoint inhibition (ICI) has revolutionized treatment for metastasized melanoma, but many patients remain unresponsive. Concerning potential adverse events, reliable biomarkers to predict ICI response are needed. In this context, neutrophil‐to‐lymphocyte ratio (NLR) and derived NLR (dNLR) have emerged. Liver metastases also limit ICI efficacy, correlating with diminished overall survival (OS) and progression‐free survival (PFS) and may siphon activated T cells from the systemic circulation, creating an ‘immune desert state’. We evaluated the predictive role of NLR and dNLR for ICI response and the impact of liver metastases on systemic immunity and treatment efficacy. Patients and Methods In this single‐center retrospective study, we included 141 stage IV melanoma patients undergoing ICI. NLR and dNLR were calculated from absolute neutrophil count, absolute lymphocyte count, and white blood cell count.

Results

Elevated NLR and dNLR were associated with poor response to ICI and inferior PFS. Patients with liver metastases exhibited higher NLR and dNLR levels and showed diminished response to ICI.

Conclusions

Elevated baseline NLR and dNLR predict poor response to ICI and PFS in stage IV melanoma. Liver metastases are negative predictors for ICI response, with associated higher NLR and dNLR levels potentially contributing to therapy resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNeutrophilsLiver NeoplasmsLymphocytesImmune Checkpoint InhibitorsSkin NeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedNeoplasm StagingAdultLymphocyte CountAged, 80 and overLeukocyte CountImmunotherapy

Stichwörter der Autor:innen

NLRcheckpointimmunotherapyliver metastasismelanomaneutrophil‐to‐lymphocyte ratio

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, TUM School of Medicine and Health, München, Germany.

ORCID-Profile: Yannick Foerster

Zitieren

APA

Foerster, Y., Mayer, K., Wasserer, S., Dechant, M., Verkhoturova, V., Heyer, S., Biedermann, T., & Persa, O. D. (2025). Elevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma. Cancer Medicine. https://doi.org/10.1002/cam4.70631

Vancouver

Foerster Y, Mayer K, Wasserer S, Dechant M, Verkhoturova V, Heyer S, et al. Elevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma. Cancer Medicine. 2025. doi:10.1002/cam4.70631

BibTeX
@article{Foerster2025,
  author = {Foerster, Yannick and Mayer, Kristine and Wasserer, Sophia and Dechant, Marta and Verkhoturova, Vitalina and Heyer, Sarah and Biedermann, Tilo and Persa, Oana-Diana},
  title = {Elevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70631}
}
Kostenlos starten →